As of January 22, 2026, the toxicology drug screening market is identifying as a pivotal sector in global health and safety, with its 2026 valuation reaching approximately $6.68 billion for screening systems alone, while the broader drug screening market is estimated at over $22.5 billion. The 2026 landscape is defined by a robust CAGR of 7.1% to 9.9%, driven by the urgent need to detect...